PATENT CLAIM ANALYSIS

Application Number: 15919395
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "558000"]

Abstract:
Compounds, called liamocins from  Aureobasidium pullulans , having the general structure in Formula 1 are disclosed. where R 1  is either COCH 3  or H; and R 2  is between two to ten O-linked 3,5-dihydroxydecanoate; and R 3  can be a polyol (e.g., L- or D-glycerol, L- or D-threitol, L- or D-erythritol, L- or D-arabitol, L- or D-xylitol, L- or D-lyxitol, L- or D-ribitol, L- or D-allitol, L- or D-altritol, L- or D-mannitol, L- or D-iditol, L- or D-gulitol, L- or D-glucitol (also called sorbitol), L- or D-galactitol (also called dulcitol), and L- or D-talitol), 2-amino-D-mannitol, 2N-acetylamino-D-mannitol, L-rhamnitol, or D-fucitol; except when R 3  is D-mannitol, R 2  is not 2 nor 3 O-linked 3,5-dihydroxydecanoate chains. These liamocins described above in addition to D-mannitol liamocin A1, D-mannitol liamocin A2, D-mannitol liamocin B1, and D-mannitol liamocin B2, alone or in combination with each other, can be used to kill certain bacteria and to treat certain bacterial infections.

Claim (Index 6):
A method of producing threitol-liamocins comprising culturing  Aureobasidium pullulans  on a media containing L-threitol as a carbon source.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 90.0
- Lexical Diversity: 2.15556
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15126182', '15212471', '11447553', '12330723', '15121515']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7032430471501582
- 35 USC 102 Novelty (BERT): 0.6102547344057514
- Combined Prediction Score: 0.6939442158757175
- Mean Citation Score: 288.085744
- Max Citation Score: 689.7689
- Similarity Product: 435.0165186670661

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test